Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#51 / 200 Total
ABVC - ABVC BioPharma Inc - Stock Price Chart
TickerABVC [NASD]
CompanyABVC BioPharma Inc
CountryUSA
IndustryBiotechnology
Market Cap59.61MEPS (ttm)-0.14
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y27.39%
P/S116.88EPS next 5Y-
P/B9.99EPS Q/Q86.06%
Dividend-Sales Q/Q-100.00%
Insider Own14.33%Inst Own1.69%
Insider Trans0.00%Inst Trans-58.04%
Short Float4.43%Earnings-
Analyst Recom3.00Target Price20.20
Avg Volume418.38K52W Range0.40 - 5.48
ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.
MIST - Milestone Pharmaceuticals Inc - Stock Price Chart
TickerMIST [NASD]
CompanyMilestone Pharmaceuticals Inc
CountryCanada
IndustryBiotechnology
Market Cap73.78MEPS (ttm)-0.83
P/E-EPS this Y-30.60%
Forward P/E-EPS next Y-13.90%
PEG-EPS past 5Y28.21%
P/S-EPS next 5Y4.69%
P/B-EPS Q/Q-51.74%
Dividend-Sales Q/Q-
Insider Own1.06%Inst Own22.27%
Insider Trans0.00%Inst Trans-39.21%
Short Float3.72%EarningsMay 14/b
Analyst Recom2.00Target Price3.33
Avg Volume1.38M52W Range0.63 - 2.75
Milestone Pharmaceuticals, Inc. engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients. It develops etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, rapid ventricular rate, and other cardiovascular indications. The company was founded by Philippe Douville and Philippe Lamarre in 2003 and is headquartered in Montreal, Canada.
ZTEK - Zentek Ltd - Stock Price Chart
TickerZTEK [NASD]
CompanyZentek Ltd
CountryCanada
IndustryMedical Instruments & Supplies
Market Cap100.52MEPS (ttm)-0.07
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-35.94%
P/S164.79EPS next 5Y-
P/B9.78EPS Q/Q32.04%
Dividend-Sales Q/Q13182.91%
Insider Own5.30%Inst Own1.49%
Insider Trans0.00%Inst Trans-8.75%
Short Float0.03%Earnings-
Analyst Recom-Target Price-
Avg Volume49.41K52W Range0.50 - 1.84
Zentek Ltd. engages in the research, development, and commercialization of graphene-based novel products. Its platform, ZenGuard, offers bacterial and viral filtration efficiency of both surgical masks, and heating, ventilation, and air conditioning systems. The company was founded on July 29, 2008 and is headquartered in Guelph, Canada.
ITRM - Iterum Therapeutics Plc - Stock Price Chart
TickerITRM [NASD]
CompanyIterum Therapeutics Plc
CountryIreland
IndustryBiotechnology
Market Cap40.00MEPS (ttm)-1.00
P/E-EPS this Y57.87%
Forward P/E-EPS next Y82.67%
PEG-EPS past 5Y29.27%
P/S-EPS next 5Y55.20%
P/B-EPS Q/Q68.79%
Dividend-Sales Q/Q-
Insider Own2.19%Inst Own1.93%
Insider Trans0.00%Inst Trans-4.25%
Short Float3.03%EarningsMay 13/b
Analyst Recom1.00Target Price7.00
Avg Volume579.98K52W Range0.81 - 3.02
Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.
JAGX - Jaguar Health Inc - Stock Price Chart
TickerJAGX [NASD]
CompanyJaguar Health Inc
CountryUSA
IndustryBiotechnology
Market Cap3.17MEPS (ttm)-162.76
P/E-EPS this Y87.03%
Forward P/E-EPS next Y81.57%
PEG-EPS past 5Y86.61%
P/S0.27EPS next 5Y85.48%
P/B0.90EPS Q/Q80.83%
Dividend-Sales Q/Q-5.83%
Insider Own16.77%Inst Own8.23%
Insider Trans0.00%Inst Trans0.11%
Short Float2.11%EarningsMay 15/b
Analyst Recom1.00Target Price28.00
Avg Volume147.85K52W Range2.43 - 110.75
Jul-10-25 08:30AM Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs (ACCESSWIRE)
Jul-08-25 09:00AM Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institute of Agrarian Innovation (INIA) Supports Research Efforts of Jaguar Health and Filament Health Joint Venture, Magdalena Biosciences, into Potential Mental Health and CNS Indications of Coca (ACCESSWIRE)
Jun-30-25 09:00AM Proof-of-Concept Results Show Jaguar Health's Crofelemer Reduced Total Parenteral Nutrition in Third Intestinal Failure Orphan Disease Patient (ACCESSWIRE)
Jun-26-25 09:15AM Jaguar Health to pursue approval of Canalevia in EU for general diarrhea in dogs (TipRanks) -7.19%
09:00AM Jaguar Health Board of Directors Authorizes Company to Include Cryptocurrency as a Treasury Reserve Asset (ACCESSWIRE)
Jun-25-25 09:00AM Jaguar Health to Pursue Approval of Canalevia in European Union for Treatment of General Diarrhea in Dogs (ACCESSWIRE)
Jun-24-25 04:15PM Jaguar Health Announces Extension of the Maturity Date of its Convertible Promissory Notes from Recently Closed Bridge Financing to January 30, 2026 (ACCESSWIRE) +12.96%
Jun-23-25 09:00AM Jaguar Health Provides Updates on Orphan Disease Intestinal Failure Development Program for Crofelemer (ACCESSWIRE)
Jun-17-25 09:00AM Jaguar Health Presenting June 18 at Emerging Growth Conference to Provide Updates on Near-Term Catalysts (ACCESSWIRE) -6.23%
07:00AM Presenting on Emerging Growth Conference 83 Day 2 on June 18; Register to live stream (GlobeNewswire)
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. It operates through the Human Health and Animal Health segments. The Human Health segment is involved in manufacturing human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment includes commercializing prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.
STKH - Steakholder Foods Ltd ADR - Stock Price Chart
TickerSTKH [NASD]
CompanySteakholder Foods Ltd ADR
CountryIsrael
IndustryPackaged Foods
Market Cap1.46MEPS (ttm)-11.48
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y1.21%
P/S145.80EPS next 5Y-
P/B0.31EPS Q/Q-362.55%
Dividend-Sales Q/Q-100.00%
Insider Own-Inst Own5.68%
Insider Trans-Inst Trans45.64%
Short Float-Earnings-
Analyst Recom1.00Target Price250.00
Avg Volume1.11M52W Range1.33 - 17.85
Steakholder Foods Ltd. is an international deep-tech food company, which engages in the provision of production technology and associated supplies needed to commercially produce structured alternative protein products. The firm is also involved in developing and selling two types of 3D-printing production machines and developing plant-based products that aim to replicate the complex textures of traditional meats such as beef steaks, white fish, shrimp, and eel. The company was founded by Arik Kaufman, Yaron Kaiser, Sharon Fima, and Omri Schanin on July 22, 1992 and is headquartered in Rehovot, Israel.
ADGM - Adagio Medical Holdings Inc - Stock Price Chart
TickerADGM [NASD]
CompanyAdagio Medical Holdings Inc
CountryUSA
IndustryMedical Devices
Market Cap23.07MEPS (ttm)-11.04
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-816.44%
P/S39.77EPS next 5Y-
P/B1.86EPS Q/Q95.12%
Dividend-Sales Q/Q-100.00%
Insider Own1.81%Inst Own75.37%
Insider Trans0.00%Inst Trans64.23%
Short Float0.97%Earnings-
Analyst Recom-Target Price-
Avg Volume2.06M52W Range0.62 - 11.57
Adagio Medical Holdings, Inc. is a medical device company, which engages in the development ablation technologies for the treatment of cardiac arrhythmias. It treats atrial fibrillation, atrial flutter, and ventricular tachycardia. The company was founded on August 24, 2020 and is headquartered in Laguna Hills, CA.
TRNR - Interactive Strength Inc - Stock Price Chart
TickerTRNR [NASD]
CompanyInteractive Strength Inc
CountryUSA
IndustryPersonal Services
Market Cap9.73MEPS (ttm)-19100.72
P/E-EPS this Y96.70%
Forward P/E-EPS next Y56.66%
PEG-EPS past 5Y52.18%
P/S1.53EPS next 5Y-
P/B0.40EPS Q/Q99.94%
Dividend-Sales Q/Q273.55%
Insider Own0.01%Inst Own1.36%
Insider Trans0.00%Inst Trans-
Short Float9.56%EarningsMay 19/a
Analyst Recom1.00Target Price15.00
Avg Volume462.32K52W Range3.74 - 990.00
Jul-09-25 02:15PM Interactive Strength Inc. (Nasdaq: TRNR) Receives "Buy" Rating and $15 Price Target in Maxim Group Research Initiation (ACCESSWIRE) +9.67%
Jul-01-25 08:10AM Interactive Strength Inc. (Nasdaq: TRNR) Completes Acquisition of Wattbike, Creating a Diversified Global Fitness Platform on Track for More than $75 Million in Pro Forma 2025 Revenue (ACCESSWIRE)
Jun-25-25 08:00AM Interactive Strength Inc. (Nasdaq:TRNR) Announces 1-for-10 Reverse Split (ACCESSWIRE) -34.50%
Jun-18-25 08:00AM Interactive Strength Inc. (Nasdaq:TRNR) Expects to Complete Wattbike Acquisition Imminently After Receiving UK Regulatory Approval (ACCESSWIRE)
Jun-16-25 08:00AM Interactive Strength Inc. (Nasdaq:TRNR) Closes Initial $55 Million Investment for Crypto Treasury Strategy and Begins Acquiring $FET (ACCESSWIRE) +6.17%
Jun-13-25 08:00AM Interactive Strength Inc. (Nasdaq:TRNR) Updates FAQ's About $500M AI-focused $FET Treasury Strategy (ACCESSWIRE) -13.43%
Jun-11-25 08:00AM Interactive Strength Inc. (Nasdaq:TRNR) Enters into $500 Million Facility to Acquire AI-focused $FET Tokens and Launch Crypto Treasury Asset Strategy (ACCESSWIRE) +14.30%
08:00AM Fitness Firm Interactive Strength Plans to Raise Up to $500M to Buy Fetch.AI's FET Tokens (CoinDesk)
May-23-25 08:00AM Interactive Strength Inc. (Nasdaq:TRNR) Shares New CEO Q&A Update Featuring TRNR and Wattbike CEO's (ACCESSWIRE) -11.22%
May-21-25 08:00AM Interactive Strength Inc. (Nasdaq:TRNR) Updates FAQ's In Response To Additional Shareholder Questions (ACCESSWIRE)
Interactive Strength, Inc. engages in the development and sale of an at-home fitness technology platform. It offers Forme, a digital fitness service that combines fitness hardware products with personal training and coaching services. It operates under the following geographical segments: the United States, the United Kingdom, and Taiwan. The company was founded by Trent A. Ward and Ben Bartlett on May 8, 2017 and is headquartered in Austin, TX.
KLXE - KLX Energy Services Holdings Inc - Stock Price Chart
TickerKLXE [NASD]
CompanyKLX Energy Services Holdings Inc
CountryUSA
IndustryOil & Gas Equipment & Services
Market Cap30.02MEPS (ttm)-3.52
P/E-EPS this Y-18.73%
Forward P/E-EPS next Y18.75%
PEG-EPS past 5Y31.45%
P/S0.04EPS next 5Y-
P/B-EPS Q/Q-17.64%
Dividend-Sales Q/Q-11.85%
Insider Own18.56%Inst Own34.20%
Insider Trans-2.00%Inst Trans2.57%
Short Float11.57%EarningsAug 07/b
Analyst Recom1.00Target Price5.00
Avg Volume189.63K52W Range1.51 - 7.66
KLX Energy Services Holdings, Inc. engages in the provision of completion, intervention and production services and products to onshore oil and gas producing regions. It operates through the following geographical segments: Southwest, Rocky Mountains and Northeast. The company was founded in 2018 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lehner Keefer McGovernOfficerJun 27 '25Proposed Sale2.005,50011,000Jun 26 05:42 PM
MCCAFFREY THOMAS PDirectorMay 13 '25Sale1.9550,04597,588143,441May 14 09:39 PM
MCCAFFREY THOMAS PDirectorMay 13 '25Proposed Sale1.9550,04597,681May 14 10:51 AM
Lehner Keefer McGovernOfficerMar 26 '25Proposed Sale3.601,0003,600Mar 26 11:38 AM
Stanford Geoffrey CSee RemarksMar 19 '25Sale3.756,33623,76028,836Mar 21 08:22 PM
DPRO - Draganfly Inc - Stock Price Chart
TickerDPRO [NASD]
CompanyDraganfly Inc
CountryCanada
IndustryAerospace & Defense
Market Cap19.06MEPS (ttm)-3.11
P/E-EPS this Y63.08%
Forward P/E-EPS next Y51.30%
PEG-EPS past 5Y26.61%
P/S3.91EPS next 5Y-
P/B18.59EPS Q/Q30.08%
Dividend-Sales Q/Q9.41%
Insider Own1.42%Inst Own7.78%
Insider Trans0.00%Inst Trans0.78%
Short Float17.38%EarningsMay 08/a
Analyst Recom1.00Target Price5.25
Avg Volume1.11M52W Range1.55 - 6.09
Draganfly, Inc. engages in the manufacture and sale of commercial unmanned aerial vehicle systems and software serving the public safety, agriculture, industrial inspections, security, mapping, and surveying markets. Its products include quad-copters, fixed wing aircrafts, ground based robots, hand held controllers, and software used for tracking, live streaming, and data collection. The firm also offers custom engineering, training, simulation consulting, as well as data and flight training services. The company was founded by Zenon Dragan and Christine Dragan in 1998 and is headquartered in Saskatoon, Canada.
123456789101120